Journals / Tüberküloz ve Toraks / 2008 / Cilt: 56 - Sayı: 1

Parapnömonik efüzyon ve ampiyemin tanı ve tedavisinde yeni eğilimler

New trends in the diagnosis and treatment in parapneumonic effusion and empyema

Pages
113–120
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If the lung does not reexpand completely with thoracoscopy, then decortication should be performed without delay.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Despite treatment with antibiotics, patients with complicated parapneumonic effusion (PPE) and empyema have an increased morbidity and mortality due at least in part to inappropriate management of the pleural effusion.
📊
Key Findings & Data:If the effusion is more than 10 mm in thickness, a therapeutic thoracentesis should be performed.
💡
Conclusion & Impact:If the lung does not reexpand completely with thoracoscopy, then decortication should be performed without delay.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Despite treatment with antibiotics, patients with complicated parapneumonic effusion (PPE) and empyema have an increased morbidity and mortality due at least in part to inappropriate management of the pleural effusion. PPE should be considered in all patients with pneumonia as antibiotic therapy is being initiated. If the diaphragms cannot be seen throughout their length on the chest radiographs, a lateral decubitus radiograph, ultrasonography or computerized tomography scan should be obtained. If the effusion is more than 10 mm in thickness, a therapeutic thoracentesis should be performed. If the fluid cannot all be removed and the characteristics of the pleural fluid indicate a poor prognosis, a chest tube should be inserted. If the drainage is incomplete due to loculation of the PPE intrapleural fibrinolytics or thoracoscopy should be performed. If the lung does not reexpand completely with thoracoscopy, then decortication should be performed without delay.

Özet

Antibiyotik tedavisine rağmen parapnömonik efüzyon (PPE) ve ampiyem morbidite ve mortalitesinde kısmende olsa yönetim hataları nedeniyle artış olmaktadır. PPE antibiyotik tedavisi başlanan tüm pnömoni olgularında akla getirilmelidir. Eğer göğüs röntgenogramında diyaframlar boylu boyunca görülemiyorlarsa yan dekübit grafisi, ultrasonografi ya da bilgisayarlı tomografi çekilmelidir. Eğer efüzyon 10 mm’den daha kalınsa tedavi edici torasentez yapılmalıdır. Eğer sıvı tamamen boşaltılamaz ve sıvı özellikleri kötü prognozu işaret ediyorsa göğüs tüpü takılmalıdır. Eğer PPE’nin loküle olmasına bağlı tam drenaj olmuyorsa intraplevral fibrinolitikler ya da torakoskopi uygulanmalıdır. Eğer torakoskopi ile akciğer tam açılmazsa gecikmeden dekortikasyon yapılmalıdır.

🔖

Cite This Article

DİKENSOY, Ö., LIGHT, R. W., NA, M. J. (2022). Parapnömonik efüzyon ve ampiyemin tanı ve tedavisinde yeni eğilimler. Tüberküloz ve Toraks, Cilt: 56 - Sayı: 1, 113–120. https://ajindex.com/articles/618984

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Light RW. Parapneumonic effusions and empyema. In: Light RW (eds). Pleural Disease. 4th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 151-81
  2. Davies CW, Gleeson FV, Davies RJ. BTS guidelines for the management of pleural infection. Thorax 2003; 58 (Suppl2): 18-28
  3. Light RW, Rodriguez RM. Management of parapneumonic effusions. Clin Chest Med 1998; 19: 373-82
  4. Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community- acquired pneumonia: Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-26
  5. Light RW, Girard WM, Jenkinson SG, George RB. Parapneumonic effusions. Am J Med 1980; 69: 507-11
  6. Davies CW, Kearney SE, Gleeson FV, Davies RJ. Predictors of outcome and long-term survival in patients with pleural infection. Am J Respir Crit Care Med 1999; 160:1682-7
  7. Chen KY, Hsueh PR, Liaw YS, et al. A 10-year experience with bacteriology of acute thoracic empyema: Emphasis on Klebsiella pneumoniae in patients with diabetes mellitus. Chest 2000; 117: 1685-9
  8. Ashbaugh DG. Empyema thoracis. Factors influencing morbidity and mortality. Chest 1991; 99: 1162-5
  9. Huang HC, Chang HY, Chen CW, et al. Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion for empyema. Chest 1999; 115: 751-6
  10. Heffner JE, McDonald J, Barbieri C, Klein J. Management of parapneumonic effusions. An analysis of physician practice patterns. Arch Surg 1995; 130: 433-8
  11. Ferguson AD, Prescott RJ, Selkon JB, et al. The clinical course and management of thoracic empyema. QJM 1996; 89: 285-9
  12. Lim TK. Management of parapneumonic pleural effusion. Curr Opin Pulm Med 2001; 7: 193-7
  13. Bartlett JG, Gorbach SL, Thadepalli H, Finegold SM. Bacteriology of empyema. Lancet 1974; 303: 338-40
  14. Evans AL, Gleeson FV. Radiology in pleural disease: State of the art. Respirology 2004; 9: 300-12
  15. Taryle DA, Potts DE, Sahn SA. The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest 1978; 74: 170-3
  16. Kocijancic I, Vidmar K, Ivanovi-Herceg Z. Chest sonography versus lateral decubitus radiography in the diagnosis of small pleural effusions. J Clin Ultrasound 2003;31: 69-74
  17. Wu RG, Yuan A, Liaw YS, et al. Image comparison of real- time gray-scale ultrasound and color Doppler ultrasound for use in diagnosis of minimal pleural effusion. Am J Respir Crit Care Med 1994; 150: 510-4
  18. Jones